The Future of Pharma

My guests in this episode are Sarah D'Alessio, Dorrian Fragola, and Brooke Cote- three accomplished professionals whose careers span engineering, business development, and market growth, and who aare each helping shape the future of our industry in our own way. Sarah D'Alession is Process Engineering Group Manager for Hart Design Group. Sarah is a process engineering leader specializing in capital...

My guest in this episode is Michelle Davey. Michelle is currently serving as the CEO of Wheel Health. Under her guidance, Wheel has become the leading platform to connect qualified healthcare professionals with virtual care opportunities. Wheel's groundbreaking Horizon platform is Michelle's latest initiative, a cutting-edge solution that integrates artificial intelligence into healthcare delivery...

My guest in this episode is Sanjeev Luther. Sanjeev is President & CEO of Ernexa Therapeutics. He is a seasoned life sciences leader with decades of experience in oncology, biotechnology innovation, and corporate leadership across global markets. He has guided clinical-stage biopharmaceutical companies through corporate strategy, R&D, licensing, regulatory affairs, and operations, overseeing globa...

My Guest in this episode is Dr. Dave Miller. Dave is CSO of AustinPx and leads the pharmaceutics and analytical development teams and oversees the application of the KinetiSol™ Technology. Prior to his current position, Dr. Miller served as Vice President of Research and Development at DisperSol Technologies and Senior Principal Scientist at Hoffmann-La Roche. Dr. Miller is a co-inventor of the ph...

My guest in this episode is Brandon Rice. Brandon is the CEO and co-founder at Weave Bio, a software company focused on automating regulatory submissions in the pharmaceutical industry using AI where he oversees product development, specifically leading the creation of AutoIND, their AI-powered platform for IND preparation.   In this conversation, Brandon discusses his journey to co-founding Weave...

My guest in this episode is Nikkhil Masurkar.  Nikkhil is the CEO of Entod Pharmaceuticals which is based in India. He is often called India's Eye Drops Man because Entod specializes in ophthalmic, ENT, and dermatological medicines.  In this interview, Nikkil and I talked about how closely American and Indian pharma worlds are intertwined - 4 out of 10 prescriptions filled in the U.S. are supplied...

My guest in this episode is Arielle Smith.  Arielle serves as the President of Life Science at Event Cadence which is an event management platform. She was also one of the founding members of Event Cadence. It enables Life Science companies to efficiently plan and manage both industry conferences and internal meetings. Arielle has worked with pharma companies such as Merck, AstraZeneca, Jazz Pharm...

My guest in this episode is Ray Jordan. Ray is Principal at Putnam Insights. Ray Jordan is a corporate affairs leader and reputational growth driver in healthcare, technology, biotechnology and consumer industries and has worked with or for companies such as Moderna, Amgen, Johnson & Johnson and Pfizer. Ray has been recognized numerous times by industry sources such as PRWeek, and PRovoke Media. H...

My guest in this episode is Vinay Patel.  Vinay is a pharmacist executive with over 18 years in the field and founder of MakoRx. He has been involved with health management, community pharmacy operations, and creating pharmacy services. Vinay has worked in various pharmacy settings including national retail, local community, hospital pharmacy, academia, and group medical practices. His efforts now...

My guest in this episode is Rene Marcotte. Rene is Senior Vice President Life Sciences at RCM Technologies. Rene has nearly 40 years of experience as a data architect across multiple industries, including Life Sciences for the past 20 years. He has helped to lead and build over 40 data warehouses and analytic solutions, including for some of the largest and smallest pharmaceuticals.  In this discu...

My guest in this episode is Dr. Mohit Jain, founder and CSO of Sapient.   Dr. Jain is a physician-scientist with more than 20 years of expertise in physiology, computational biology, and mass spectrometry-based bioanalytics. He formed the Jain Laboratory at UCSD, where he led his team to develop next-generation mass spectrometry systems to probe the non-genetic landscape of disease across large-sc...

My guest in this episode is Scott Chetham.  Scott is an experienced healthcare entrepreneur who is currently the CEO and co-founder of Faro Health.  Scott leads the strategy for the Faro Health platform, which is designed to power clinical development by connecting data to decision making in a fundamentally new way. Previously, he was the Head of Clinical Research Operations and Data Management at...

My guest today is Ron Gutman. Ron is an inventor, an investor, a serial technology and healthcare entrepreneur and a Stanford University adjunct Professor.  Ron has built and invested in technology and healthcare companies that have served hundreds of millions of people and saved countless lives worldwide. He's an inventor holding a series of patents in healthcare technology and Artificial Intelli...

My guest in this episode is Nathan Clark. Nathan is the Co-Founder of Ganymede.bio, one of the fastest-growing software startups in biotech. Ganymede is the modern, data platform for life sciences companies, and its focused on integrating physical lab instruments with digital workflows. Prior to Ganymede, Nathan was the product manager at Benchling for Machine Learning and Insights Analytics. He a...

I have two guests in today's episode, something I rarely do. My guests are Kyle Felmet and Jennifer Lospinoso. Kyle Felmet serves as the Vice President of Specialty Commercialization at Two  Labs, an Envision Pharma Company, where he plays a pivotal role in ensuring that specialty drug manufacturers have the necessary distribution channel strategy infrastructure and pre-launch workstreams in place...

My guest today is Dr. Ben Coverdale.  Ben is an experienced Global Account Director of Patsnap with a demonstrated history of working in the life sciences and innovation intelligence industries. Patsnap is Powered by advanced AI, where they help IP and R&D teams collaborate and accelerate the entire innovation lifecycle. He has a strong research professional background with a Doctor of Philosophy...

My guest in this episode is Dr. Samuel Ewing. He is the Global Head of Pharmaceutical Partnerships at Doccla. Before joining Doccla, Dr. Ewing led the development of a connected auto-injector system for Roche's Alzheimer's disease program at Capgemini Engineering. He also led the development of Biofourmis's wearable vital sign monitoring platform. At Roche, he managed remote patient monitoring acr...

My guest in this episode is Greg Kunst, CEO of Aurion Biotech. At Aurion, Greg and his colleagues are working on a regenerative treatment (corneal endothelial cell therapy) for millions of people who have partial or complete vision loss. Greg joined Aurion Biotech with deep and varied experience in ophthalmic medical devices, drug delivery systems, diagnostics, biotechnology, and pharmaceutical pr...

My guest in this episode of The Future of Pharma is Nikhil Bhojwani.  Nikhil is an entrepreneur, investor, strategist, and TedTalk speaker. He is a Managing Partner at Recon Strategy, a boutique consulting firm that he founded in 2010. At Recon Strategy, Nikhil works with executives and boards on strategy at the portfolio and business-unit levels for payers, hospitals, life science, and digital he...

My guest in this episode is Dr. Harsha Rajasimha, CEO/founder of Jeeva Clinical Trials. We talked about the pharmaceutical industry's blackbox - clinical trials. Personal tragedy inspired him to dedicate his life to make technology more efficient for healthcare solutions including AI and generative AI. We discussed the complexities of clinical trials, its patient recruitment, and data unavailabili...

My guest today is Hon. Prof. Dr. Tom Chittenden, but he prefers to go by Tom. He is the Chief Scientific Officer and President of R&D at BioAI Company and leads scientific research operations and ongoing development and implementation of the BioAI Health PREDICT-X Drug Discovery and Development platform. Tom Chittenden is an Honorary Professor of AI in Biomedicine at Queen Mary University of Londo...

My guests today are the dynamic husband-wife duo of Alpesh and Jigisha Gandhi who jointly run Ami Polymer Pvt. Ltd. which is a leading manufacturer of silicon tubing something we use a lot in the life science industry. Starting with Alpesh and later with Jigisha, Ami Polymer is a leading silicon tubing manufacturing company in India and played an important role in COVID vaccine manufacturing. Alpe...

My guest in this episode is Gareth Shaw. Gareth Shaw is the President, the UK & Europe of Doceree, the first global network of physician-only platforms for programmatic messaging. Prior to joining Doceree, Gareth was the General Manager, Global Programmatic, of PulsePoint where he led the programmatic and operations divisions. Previously, he has held roles at Yahoo! and Experian.  Throughout his c...

My guest in this episode is Lyndsee Manna. Lyndsee is an EVP at Arria NLG, where along with her colleagues, she helps businesses derive actionable intelligence from data to make better decisions. That's the simplistic version and we go into a lot more details. In this wide-ranging episode, we talk about math, words, language, writing, technology, data analytics, success, failure, and personal choi...

My guest today is Mark Sitcoske. Mark is the Founder & CEO of High Purity New England (HPNE), based in Northern Rhode Island, just forty-five minutes south of Boston. HPNE has grown rapidly over the last few years, expanding significantly from a small team of fewer than ten employees to a firm that anticipates reaching approximately 350 employees in 2022. Mark and his growing team of deeply-experi...